Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografski detalji
Glavni autor:	Mirza, Maisa Tasnim
Daljnji autori:	Jamiruddin, Dr. Mohd. Raeed
Format:	Disertacija
Jezik:	English
Izdano:	Brac University 2023
Teme:	Aromatase inhibitors Breast cancer Ductal carcinoma in situ Estrogen receptor positive Hormonal therapy Tamoxifen. Breast > Cancer > Chemoprevention.
Online pristup:	http://hdl.handle.net/10361/18147

Similar Items

Breast cancer awareness seminars
od: Anwer Khan Modern Medical College
Izdano: (2016)

Recent advancement on breast cancer detection and treatment
od: Rahman, Sanjida
Izdano: (2023)

Natural products and their combinatory effects in breast cancer treatment
od: Siddique, Md. Ayman
Izdano: (2021)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
od: Shobnam, Sohana
Izdano: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
od: Alam, Kazi Tasnuva
Izdano: (2022)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
od: Raihan, Dilraj
Izdano: (2024)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
od: Akter, Honufa
Izdano: (2024)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
od: Iqbal, Mohammad Shamim, i dr.
Izdano: (2017)

The impact of breast cancer on women’s lives in Bangladesh
od: Mobashera, Tayeeba Tum
Izdano: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
od: Chakraborty, Anuradha
Izdano: (2024)

A review on triple-negative breast cancer and its potential treatment
od: Niasa, Jannatul Ferdous
Izdano: (2023)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
od: Araf, Faiaz Fahim
Izdano: (2024)

Machine learning as an indicator for breast cancer prediction
od: Shadman, Tahsin Mohammed, i dr.
Izdano: (2019)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
od: Nuha, Nabiha Tahsin
Izdano: (2024)

Breast cancer therapy through Liposomal drug delivery system
od: Ome, Nusrat Jahan
Izdano: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
od: Lamia
Izdano: (2020)

Early detection of breast cancer using machine learning
od: Fuad, Wasi Mohammad
Izdano: (2019)

Breast cancer in South Asia: a Bangladeshi perspective
od: Hossain, Mohammad Sorowar, i dr.
Izdano: (2017)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
od: Parvin, Salma, i dr.
Izdano: (2016)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
od: Oishy, Jannatun Noor
Izdano: (2024)

Breast cancer prediction using different machine learning models
od: Khandker Al- Muhaimin, i dr.
Izdano: (2020)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
od: Bristy, Israt Zerin
Izdano: (2021)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
od: Hasan, Sakib
Izdano: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
od: Monayem, Kazi Fahim
Izdano: (2024)

Exploring the use of Ingenol Mebutate to prevent non-melanoma skin cancer: A review
od: Haque, Fariha
Izdano: (2023)

Machine learning In breast cancer prognosis and prediction
od: Chowdhury, Shah Abul Hasnat, i dr.
Izdano: (2023)

Elucidating the functional roles of bidirectionally transcribed genes in immunobiology of cancers
od: Ahmad, Sheikh Shafin
Izdano: (2021)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
od: Rahman, Sanjida
Izdano: (2024)

Statistics and informatics in molecular cancer research

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
od: Karim, Azrin
Izdano: (2024)

Immunotherapy in the treatment of renal cancer
od: Shimu, Sumaya
Izdano: (2022)

Effect of passive immunization with mouse Anti-BCG 64 kDa protein on ehrlich ascites carcinoma cells
od: Chowdhury, Maisha Mosharrat
Izdano: (2018)

Cancer risk factors: a critical review
od: Tabassum, Tahsina
Izdano: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
od: Nawar, Anika
Izdano: (2019)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
od: Zangmo, Thinley
Izdano: (2024)

Application of deep convolutional neural network in breast cancer prediction using Digital Mammograms
od: Al Mamun, Rafsan, i dr.
Izdano: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
od: Abir, Shifaty Nur
Izdano: (2024)

Targeting BRAFV600E in the treatment of CRC
od: Roja, Mashwiyat Samrin
Izdano: (2024)

Role of statins as antagonists of SPARC in gastric cancer
od: Shahmat, Rad
Izdano: (2019)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
od: Pial, Sazia Afrin
Izdano: (2018)